Double tract reconstruction for the management of small intestinal bacterial overgrowth after Roux-en-Y gastric bypass.
Paul Rat, Robin Grellet, Olivier Facy, Nicolas Santucci
Journal of minimal access surgery
42616998
August 13, 2026
Quality Indicators
Abstract Only: Full text of this study is not publicly available. This summary is based on the abstract only and may be less detailed than usual.
AI-Generated Summary: This summary was created by AI and may contain errors. Always consult healthcare professionals and read the original study for medical decisions.
Study Summary
AI-generated overview of this research
Quick Summary
This small case series examined whether double tract reconstruction surgery could help manage small intestinal bacterial overgrowth (SIBO) in patients who developed it after weight-loss surgery. Among 5 patients who had the procedure between 2020-2023, 3 showed significant symptom improvement and 2 were completely cured of chronic diarrhea, though 2 patients had no improvement.
What Was Studied
Researchers examined the safety and effectiveness of double tract reconstruction (a surgical procedure that reroutes the digestive tract) in 5 patients who developed SIBO after having Roux-en-Y gastric bypass (a type of weight-loss surgery). Patients were only selected if they had a positive breath test for SIBO, failed medical treatment with antibiotics or other medications, and didn't have other anatomical problems that could explain their symptoms.
How the Study Was Conducted
The study tracked patients who underwent double tract reconstruction between January 2020 and December 2023. Researchers recorded body mass index, reflux symptoms, and SIBO-related symptoms before and after surgery. All patients had confirmed SIBO through breath testing and had not responded to conservative (non-surgical) treatments before being offered the procedure. Full methodology not publicly available — summary based on abstract only.
Key Findings
- All 5 patients recovered from surgery without complications, with a median hospital stay of 2 days
- All patients showed significant symptom improvement at their first follow-up appointment after surgery
- By final follow-up, 3 out of 5 patients (60%) had significant lasting improvement, including 2 who were completely cured of chronic diarrhea, while 2 patients had no sustained improvement
- No patients experienced weight regain or new reflux symptoms after the procedure
Important Limitations
- Extremely small sample size (only 5 patients) makes it difficult to draw broad conclusions about effectiveness or safety
- No control group or comparison to other treatment approaches for SIBO after gastric bypass
- Length of follow-up not specified — unclear how long symptom improvements lasted
- Full text not publicly available — summary based on abstract only
Was this summary helpful?
Related Studies
Coming soon: See other studies on similar topics